CRK antibody
Principal name
CRK antibody
Alternative names for CRK antibody
Proto-oncogene C-crk, p38, Adapter molecule crk
Ncbi ID
9606, NP_005197, NP_005197.3, NM_005206, NP_058431, NP_598417.2, NM_133656, NM_019302, NM_016823
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), Immunocytochemistry/Immunofluorescence (ICC/IF), Paraffin Sections (P), Dot blot (Dot), ELISA (detection) (E(detection))
Background of CRK antibody
The Crk family of adapter proteins including Crk II, Crk I and Crk L consist mostly of SH2 and SH3 domains. Through the interactions between SH2 domain and phosphotyrosine residues and/or between SH3 domain and proline- rich motifs, they are involved in a variety of signaling cascades. Crk I and Crk II are encoded by the same gene, which undergoes alternative splicing to yield these two proteins, but differ in their biological activities. Crk II has less transforming activity than Crk I, although both Crk I and Crk II bind to many tyrosine-phosphorylated proteins that bind to GRB2. In addition, Crk II becomes rapidly tyrosine-phosphorylated in response to stimulation with insulin-like growth factor-I (IGFI) and might be involved in the IGF-I receptor signalling pathway. The gene encoding Crk I and II maps to human chromosome 17p13, a region which demonstrates frequent deletion or loss of heterozygosity in a wide range of human cancers.
General readings
Muir TW., et al (2006) Biochemistry. 45(29):8874-84.
Inagaki F., et al. (2007) Nat Struct Mol Biol. 14(6):503-10.






















- Quick-Filters:
- Highly Validated (2)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| AM06667SU-N | CRK antibody |
||||||
![]() |
Mouse | IgG2b | 3G11C1 | Ascites | Hu | E, ICC/IF, P, WB |
0.1 ml /
$410.00
|
| OriGene Technologies GmbH | |||||||
+6 additional images |
Highly validated antibody! |
||||||
| AM06668SU-N | CRK antibody |
||||||
![]() |
Mouse | IgG2b | 3G11E8 | Ascites | Hu | E, ICC/IF, P, WB |
0.1 ml /
$410.00
|
| OriGene Technologies GmbH | |||||||
+3 additional images |
Highly validated antibody! |
||||||
| TA325390 | CRK antibody |
||||||
| Rabbit Polyclonal CrkII Antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu, Ms, Rt | WB |
0.1 ml /
$335.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA346922 | CRK antibody |
||||||
| Mouse Monoclonal CrkII Antibody | |||||||
![]() |
Mouse | IgG2b | 3H7-E5-H8 | Purified | WB |
0.1 ml /
$335.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA349831 | CRK antibody |
||||||
| Rabbit Polyclonal Anti-CRK Antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, P |
0.1 ml /
$335.00
|
|
| OriGene Technologies, Inc. | |||||||
| AP06075PU-N | CRK antibody |
||||||
![]() |
Rabbit | Aff - Purified | Hu, Ms, Rt | E, ICC/IF, P, WB |
0.1 mg /
$370.00
|
||
| OriGene Technologies GmbH | |||||||
+1 additional image |
|||||||
| AP12756PU-N | CRK pSer41 antibody |
||||||
![]() |
Rabbit | Ig | Aff - Purified | Hu |
0.4 ml /
$415.00
|
||
| OriGene Technologies GmbH | |||||||
| AP20934PU-N | CRK (CRK-II, pTry221) antibody |
||||||
![]() |
Rabbit | Aff - Purified | Hu, Ms, Rt | P |
0.1 mg /
$370.00
|
||
| OriGene Technologies GmbH | |||||||
| AP21022PU-N | CRK (CRK-II) antibody |
||||||
![]() |
Rabbit | Aff - Purified | Hu, Ms, Rt | P |
0.1 mg /
$370.00
|
||
| OriGene Technologies GmbH | |||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP301701 | CRK (transcript variant II) |
||||
| Recombinant protein of human v-crk sarcoma virus CT10 oncogene homolog (avian) (CRK), transcript variant II | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
$748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP303438 | CRK (transcript variant I) |
||||
| Recombinant protein of human v-crk sarcoma virus CT10 oncogene homolog (avian) (CRK), transcript variant I | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
$748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY417443 | CRK overexpression lysate |
|
![]() |
0.1 mg /
$295.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR204260L2V | Lenti ORF particles, Crk (GFP-tagged) - Mouse v-crk sarcoma virus CT10 oncogene homolog (avian) (Crk), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
$930.00
|
|
| OriGene Technologies, Inc. | ||
| MR204260L1V | Lenti ORF particles, Crk (Myc-DDK-tagged) - Mouse v-crk sarcoma virus CT10 oncogene homolog (avian) (Crk), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
$830.00
|
|
| OriGene Technologies, Inc. | ||
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR201929L2V | Lenti ORF particles, Crk (GFP-tagged ORF) - Rat v-crk sarcoma virus CT10 oncogene homolog (avian) (Crk), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
$930.00
|
|
| OriGene Technologies, Inc. | ||
| RR201929L1V | Lenti ORF particles, Crk (Myc-DDK-tagged ORF) - Rat v-crk sarcoma virus CT10 oncogene homolog (avian) (Crk), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
$830.00
|
|
| OriGene Technologies, Inc. | ||















+6 additional images








